Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

✍ Scribed by David Olmos; Sophie Postel-Vinay; L Rhoda Molife; Scott H Okuno; Scott M Schuetze; M Luisa Paccagnella; Gretchen N Batzel; Donghua Yin; Kathryn Pritchard-Jones; Ian Judson; Francis P Worden; Antonio Gualberto; Michelle Scurr; Johann S de Bono; Paul Haluska

• Book ID: 117785216
• Publisher: The Lancet
• Year: 2010
• Tongue: English
• Weight: 398 KB
• Volume: 11
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(09)70354-7